# Víctor G. Prieto

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/victor-g-prieto/

## Facts

| Field | Value |
| --- | --- |
| Citations | 34,657 |
| Field | Cutaneous Melanoma Detection and Management |
| h-index | 89 |
| i10-index | 453 |
| Last Known Institution | The University of Texas MD Anderson Cancer Center |
| OpenAlex ID | https://openalex.org/A5087156478 |
| ORCID iD | https://orcid.org/0000-0001-9204-7161 |
| Works | 874 |

## Researcher papers

- [Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma](https://scholariq.org/papers/neoadjuvant-adjuvant-or-adjuvant-only-pembrolizumab-in-advanced-melanoma/)
- [Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma](https://scholariq.org/papers/neoadjuvant-immune-checkpoint-blockade-in-high-risk-resectable-melanoma/)
- [Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients](https://scholariq.org/papers/specific-lymphocyte-subsets-predict-response-to-adoptive-cell-therapy-using/)

## Researcher topics

- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Nonmelanoma Skin Cancer Studies](https://scholariq.org/topics/nonmelanoma-skin-cancer-studies/)
- [Cancer and Skin Lesions](https://scholariq.org/topics/cancer-and-skin-lesions/)
- [Cutaneous lymphoproliferative disorders research](https://scholariq.org/topics/cutaneous-lymphoproliferative-disorders-research/)

## Researcher university

- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
